Ongoing Mutations in Polytreated Metastatic Cancer Patients May Create a New Chance of Treatment with Unexpected Drugs
Author(s) -
Mahmoud Mahmoud Abbass Ellithy,
Amr S. Saad,
Mahmoud Salah Abdelsalam,
Amr Elsebaei
Publication year - 2018
Publication title -
journal of cancer therapy
Language(s) - English
Resource type - Journals
eISSN - 2151-1942
pISSN - 2151-1934
DOI - 10.4236/jct.2018.911069
Subject(s) - medicine , irinotecan , pemetrexed , temozolomide , gemcitabine , dacarbazine , oncology , kras , cancer , colorectal cancer , breast cancer , erlotinib , chemotherapy , cisplatin , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom